HANNAH PARK
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NEW YORK, NY NPI 1376922682
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NY PFIZER INC. All categories
General Payments — all program years on this page
$5,687.25
- Category: General Payments
- Program years: PY2022–2024
- Record count: 97
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $5,075.37 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,065.00 | 2 |
| Food and Beverage | $937.73 | 64 |
| Travel and Lodging | $72.64 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $4,410.97 | 25 |
| ABBVIE INC. | $145.39 | 13 |
| Biogen, Inc. | $61.37 | 3 |
| Teva Pharmaceuticals USA, Inc. | $59.43 | 4 |
| Alexion Pharmaceuticals, Inc. | $53.01 | 3 |
| UCB, Inc. | $52.29 | 3 |
| Merz Pharmaceuticals, LLC | $48.70 | 2 |
| Lilly USA, LLC | $47.00 | 3 |
| Amneal Pharmaceuticals LLC | $32.45 | 2 |
| Otsuka America Pharmaceutical, Inc. | $21.86 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.93 | 1 |
| EISAI INC. | $19.77 | 1 |
| SK Life Science, Inc. | $19.60 | 1 |
| Vanda Pharmaceuticals Inc. | $18.89 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.50 | 1 |
| Corium, Inc. | $17.22 | 1 |
| Amgen Inc. | $15.29 | 1 |
| ARGENX US, INC. | $13.70 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.